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Abstract
Sterol biosynthesis, primarily associated with eukaryotic kingdoms of life, occurs as an abbreviated pathway in the
bacterium Methylococcus capsulatus. Sterol 14a-demethylation is an essential step in this pathway and is catalyzed by
cytochrome P450 51 (CYP51). In M. capsulatus, the enzyme consists of the P450 domain naturally fused to a ferredoxin
domain at the C-terminus (CYP51fx). The structure of M. capsulatus CYP51fx was solved to 2.7 Å resolution and is the
first structure of a bacterial sterol biosynthetic enzyme. The structure contained one P450 molecule per asymmetric unit
with no electron density seen for ferredoxin. We connect this with the requirement of P450 substrate binding in order to
activate productive ferredoxin binding. Further, the structure of the P450 domain with bound detergent (which replaced
the substrate upon crystallization) was solved to 2.4 Å resolution. Comparison of these two structures to the CYP51s from
human, fungi, and protozoa reveals strict conservation of the overall protein architecture. However, the structure of an
“orphan” P450 from nonsterol-producing Mycobacterium tuberculosis that also has CYP51 activity reveals marked
differences, suggesting that loss of function in vivo might have led to alterations in the structural constraints. Our
results are consistent with the idea that eukaryotic and bacterial CYP51s evolved from a common cenancestor and that
early eukaryotes may have recruited CYP51 from a bacterial source. The idea is supported by bioinformatic analysis,
revealing the presence of CYP51 genes in >1,000 bacteria from nine different phyla, >50 of them being natural CYP51fx
fusion proteins.
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Introduction
Cytochrome P450 enzymes (CYP; P450) are heme-containing
monooxygenases that play essential roles in sterol/steroid
biosynthesis and degradation, vitamin biosynthesis, detoxifi-
cation and activation of many drugs and environmental pol-
lutants, enzymatic activation of carcinogens, and the
biosynthesis of vast arrays of secondary metabolites
(Guengerich 2001). One such P450 is sterol 14a-demethylase
(CYP51), an enzyme found in all kingdoms of life, catalyzing
the same three-step monooxygenation reaction that removes
the 14a-methyl group from the nucleus of the sterol precur-
sor molecule (fig. 1). Ultimately, this reaction is required for
the biosynthesis of cholesterol in animals, ergosterol in fungi
and protozoa, and stigmasterol in plants and algae. The ster-
ols function as integral components of eukaryotic cell mem-
branes and also serve as precursors for a multitude of different
regulatory molecules, such as hormones and brassinosteroids
(Lepesheva et al. 2018). Sterols are often considered as a de-
fining signature (biomarkers) of eukaryotic organisms and are
rarely found in bacteria, which usually employ hopanoids to
facilitate cell membrane integrity (Jackson et al. 2002). Like
sterols, hopanoids are cyclic isoprenoidal lipids, and are
cyclized by closely related cyclase enzymes (Abe 2007), but
their synthesis does not require atmospheric molecular oxy-
gen. Thus, hopanoids have been used as molecular proxies for
ancient microbial life predating the enrichment of oxygen in
Earth’s atmosphere (Ourisson and Albrecht 1992; Saenz et al.
2015).
In 1971, production of sterols in bacteria was first discov-
ered biochemically in the aerobic methanotroph
Methylococcus capsulatus Bath. A truncated postsqualene
sterol pathway was predicted because only the modified lan-
osterol molecules were detected and identified
A
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experimentally (fig. 2) (Bird et al. 1971). These observations
were verified following the complete sequencing of the
M. capsulatus genome, in which only a small number of genes
encoding sterol enzyme orthologs were seen and mapped to
the sterol biosynthetic pathway (Ward et al. 2004).
Subsequently, further examples of sterol-producing bacteria
were identified, including Methylosphaera hansonii (Schouten
et al. 2000), Stigmatella aurantiaca, Nannocystis excedens
(Bode et al. 2003), Gemmata obscuriglobus (Pearson et al.
2003), Plesiocystis pacifica (Desmond and Gribaldo 2009),
Methylomicrobium alcaliphilum (Banta et al. 2015). With
the rapid advances in genomic and bioinformatic analysis,
the numbers of bacteria known to possess genes for sterol
synthesis are continually increasing (Wei et al. 2016).
Questions of the evolutionary origin of bacterial sterol bio-
synthetic machinery, as well as structural relationship of bac-
terial water-soluble CYP51 proteins to eukaryotic CYP51s
(which are membrane-bound microsomal proteins) remain
unanswered. Mycobacterium tuberculosis is the only bacterial
species with a P450 with CYP51 activity whose 3D crystal
structure has been resolved (Podust et al. 2001). However,
that structure differs profoundly from bone fide eukaryotic
CYP51 crystal structures, both in the composition of the
substrate-binding cavity/active site volume and in the loca-
tion of the substrate access channel (Lepesheva et al. 2010).
Moreover, the CYP51 gene was shown to be not essential in
My. tuberculosis physiology (McLean et al. 2006) nor essential
for cholesterol metabolism (van Wyk et al. 2019), whereas the
CYP51 gene is essential in eukaryotes. Thus, two opposite and
contradicting hypotheses on CYP51 evolution exist and re-
main unresolved to-date: 1) CYP51 and sterol biosynthesis
has a bacterial origin with soluble (nonmembrane-bound)
enzymes that are possible evolutionary ancestors for the
membrane-bound eukaryotic CYP51 P450 family (Yoshida
et al. 1997; Nelson 1999; Yoshida et al. 2000) or 2) bacterial
CYP51s are the result of horizontal gene transfer from some
early eukaryote (Debeljak et al. 2003; Rezen et al. 2004).
Although the origin and evolution of the cytochrome P450
superfamily as a whole is unknown, current thinking suggests
a role for CYP51 as the ancestral P450 progenitor with its
ability to fix atmospheric oxygen resulting in increased P450
importance in generating metabolites for membrane integ-
rity. Subsequently, this was followed by gene duplication and
evolutionary diversification leading to broad P450 function-
ality in many roles (Sezutsu et al. 2013).
To address these fundamental questions regarding P450
evolution and sterol biosynthesis, the bacterium
M. capsulatus is an excellent organism of choice because it
has a CYP51 gene and it makes sterols. Furthermore,
M. capsulatus is one of a handful of organisms discovered
to-date carrying a gene encoding P450 heme domain fused
to a ferredoxin (fx) redox partner domain (Jackson et al. 2002;
Hannemann et al. 2007; McLean et al. 2007).
Herein, we report: 1) CYP51 genes are found in >1,000
bacteria from nine different phyla establishing that horizontal
gene transfer to bacteria is extremely unlikely and supporting
a prokaryotic origin (and thus ancestral role) of CYP51 in
P450 evolution; 2) the existence of CYP51 ferredoxin fusion
proteins (CYP51fx) in >50 bacterial organisms, suggesting
that early cytochrome P450s may have initially been fusion
proteins; and 3) the first crystal structure of a bacterial sterol
biosynthetic enzyme. The P450 domain of M. capsulatus
CYP51fx is similar in protein architecture to eukaryotic
CYP51s, and not to My. tuberculosis CYP51, indicating an
evolutionary linkage between bacterial and eukaryotic sterol
14a-demethylases.
Results and Discussion
In this study, we first performed biochemical characterization
of M. capsulatus CYP51fx to confirm its enzymatic compe-
tency. Then we crystallized the fusion protein, determined the
crystal structure of its P450 domain, in the ligand-free and a
detergent-bound state, and compared these with the known
eukaryotic and My. tuberculosis CYP51 structures. Finally, we
used bioinformatic approaches to complement our
structure-functional data and provide further support for a
bacterial origin of CYP51.
Biochemical Characterization of M. capsulatus
CYP51fx
Optical Properties
The absolute absorbance spectrum of the purified protein
was typical of ferric, low-spin P450 with the maxima of the
a-, b-, and c (Soret) bands at 568, 535, and 419 nm, respec-
tively, the spectrophotometric index A419/A278¼ 1.33, and
the ratio DA393–470/DA419–470¼ 0.38 (fig. 3A). The heme
iron was readily reduced by sodium dithionite and the differ-
ence spectrum of the ferrous CO-complex had an absorbance
maximum at 448 nm (a hallmark of the cysteinate-
coordinated heme iron) with no quantifiable denatured cy-
tochrome P420 form (fig. 3B) (Omura and Sato 1964).
Binding of Sterol Substrates
Substrate titration experiments were first conducted with
lanosterol and eburicol to clarify which of the two sterols
has a higher affinity for M. capsulatus CYP51fx (and therefore
FIG. 1. CYP51 reaction. The 14a-methyl group is first converted to the alcohol, then to the aldehyde intermediate, and at the third step is removed
as formic acid with the introduction of the double bond into the sterol core.
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should be selected for cocrystallization). Though
M. capsulatus is known to synthesize lanosterol in vivo
(Bird et al. 1971), the CYP51 family amino acid sequence
alignment suggested that the enzyme might prefer eburicol,
due to the isoleucine residue at position 81. The I81 in
M. capsulatus CYP51fx corresponds to I105 in CYP51 from
the protozoan pathogen Trypanosoma cruzi, (the only eu-
karyotic sterol 14a-demethylase having Ile in this position),
and we have previously found that T. cruzi CYP51 prefers
eburicol over lanosterol (Lepesheva et al. 2006). Titration
with both sterols produced typical Type I-binding spectra,
reflecting changes in the spin state of the heme Fe atom,
with a blue shift in the Soret band maximum from 419 to
393 nm, and a DA393–470/DA418–470 ratio (2.12–2.14), indicat-
ing >95% heme iron transition from low- to high-spin form,
and the charge transfer band at 650 nm (fig. 4). The apparent
spectral dissociation constants (Kd) derived from the titration
plots were also similar, although binding of eburicol appeared
to be about twice as tight (fig. 4, Inset, Kd¼48 6 4 vs.
94 6 11 nM for lanosterol).
FIG. 2. Sterol biosynthesis and final sterol products in Methylococcus capsulatus (A) versus eukaryotes (B). (A) Methylococcus capsulatus was shown
to encode a truncated postsqualene sterol pathway that synthesizes the modified lanosterol molecules 4,4-dimethylcholesta-8,24-dien-3-ol, 4,4-
dimethylcholesta-8-en-3-ol, 4-methylcholesta-8,24-dien-3-ol, and 4-methylcholesta-8-en-3-ol. Subsequent studies have demonstrated the pro-
duction of similar sterols in other aerobic methanotrophs of the Methylococcales order within the c-Proteobacteria. (B) Chemical structures of the
major eukaryotic sterol molecules: cholesterol in animals; stigmasterol in plants and algae; and ergosterol in fungi and protozoa.


















Both lanosterol and eburicol were metabolized by
M. capsulatus CYP51fx to the 14a-demethylated products,
3b-hydroxy-4,4-dimethyl-cholesta-8,14,24-triene, and 3b-hy-
droxy-4,4-dimethyl-24-methylene-cholesta-8,14-diene, with
the same efficiency and comparable rates, 1.8 and 1.6 min1,
respectively. The turnover of obtusifoliol was 1.2 min1 (sup-
plementary table S1, Supplementary Material online). By
comparison, the turnover of obtusifoliol by My. tuberculosis
CYP51 (its preferred substrate) was 0.5 min1, when its activ-
ity was reconstituted under the same conditions (Lepesheva
et al. 2004), that is, using Escherichia coli flavodoxin/flavodoxin
reductase as electron donor partners, as detailed in Materials
and Methods. Thus, M. capsulatus CYP51fx catalyzes 14a-
demethylation of both C4-dimethylated sterols and C4-
monomethylated obtusifoliol at appreciable rates, perhaps
contrary to suggestions based on the presence of Ile81 and
the apparent binding affinities.
Because lanosterol is the M. capsulatus CYP51fx substrate
in vivo (Bird et al. 1971), this substrate was next used to verify
the ability of the fused ferredoxin domain to transfer elec-
trons to the P450 heme iron. There was no activity observed
at 2mM M. capsulatus CYP51fx (5mM spinach ferredoxin re-
ductase) under these reaction conditions, but increasing the
concentration to 10mM (25mM ferredoxin reductase)
resulted in 25% of lanosterol conversion in a 2-h reaction
(supplementary fig. S1, Supplementary Material online), sug-
gesting a possibility of both inter- and intrareduction, as was
FIG. 3. The UV-visible absolute (A) and reduced carbon monoxide complex difference (B) absorbance spectra of purified Methylococcus capsulatus
CYP51fx. The P450 concentration was3.8 mM, the optical path length was 1 cm. The specific heme content of the preparation was 15.6 nmol per
mg protein (98% of the ideal specific content [15.9 nmol per mg protein] calculated from the predicted molecular weight of the M. capsulatus
CYP51 sequence [63 kDa]).
FIG. 4. Spectral changes observed during titration of Methylococcus capsulatus CYP51fx with (A) lanosterol and (B) eburicol. Absolute (top) and
difference (bottom) spectra. The P450 concentration was2mM. Inset: The titration curves with hyperbolic fitting (quadratic Morrison equation).
The experiments were performed in duplicates, the results are presented as means 6 SD.
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proposed for flavocytochrome P450 BM3 (CYP102) from the
soil bacterium Bacillus megaterium (a natural fusion of a P450
to a cytochrome P450 reductase) (Kitazume et al. 2007).
Structural Characterization of M. capsulatus CYP51fx
Crystal Structure of the P450 Domain with the Bound Water
Molecule
We first crystallized M. capsulatus CYP51fx in the resting
(ferric) ligand-free form. The structure was solved to 2.7 Å
resolution (supplementary table S2, Supplementary Material
online) and contained one P450 molecule per asymmetric
unit. However, no electron density for the ferredoxin domain
was observed. Instead, the space above the P450 proximal
surface (the region where ferredoxin is expected to bind)
looked like a “black hole” (fig. 5A and B). We believe this is
because, in the absence of the substrate, the P450/ferredoxin
complex, even if formed, is weak, likely representing multiple
“encounter states” (also called transient complexes) where
ferredoxin can have many orientations that it adopts before
forming a final, “productive” complex (Schilder and Ubbink
FIG. 5. Crystal structure of ligand-free Methylococcus capsulatus CYP51 (PDB ID 6mi0). (A) A Coot snapshot of the 2F0–Fc electron density map
(contoured at 1.5 r), map radius 50 Å. The density for the near P450 chains from the neighboring unit cells is seen at the top, left and right, the
density for the fx domain is missing. (B) Ribbon representation of the P450 domain structure (blue, upper P450 face) and the fx domain model
(magenta). Orientation is about the same as in (A). The residues that are expected to be involved in the (productive) protein–protein interaction
are shown and labeled. (C) Superimposition of the M. capsulatus P450 domain with the Trypanosoma brucei (plum, PDB ID 3g1q, Ca RMSD, 1.6 Å),
human (tan, PDB ID 4uhi, Ca RMSD, 1.7 Å), and Candida albicans (pink, PDB ID 5tz1, Ca RMSD, 1.9 Å) CYP51 orthologs. (D) Superimposition with
CYP51 from Mycobacterium tuberculosis (red, PDB ID 1e9, Ca RMSD, 5.4 Å). The substrate entrances are marked with the arrow of the
corresponding color. (E) Heme support in M. capsulatus (blue), My. tuberculosis (red), and T. brucei (plum) structures. Y103, R361, and H420
(T. brucei numbering) are invariant across the whole CYP51 family, Y116 corresponds to F in bacterial and plant sequences, and R124 is protozoa-
specific, its role being played by a Lys (located one turn downstream of helix C) in animal and fungal CYP51. Distal P450 face. The residues that
correspond to T. brucei Y116 and R124 in the bacterial structures are shown in wire representation and labeled.
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2013; Bowen et al. 2018) with the P450 domain.
Physiologically, the electron transfer process between redox
partner proteins and P450s takes place after a P450 enzyme
binds its substrate (Guengerich and Yoshimoto 2018). The
large-scale conformational switch that accompanies binding
of the substrate in eukaryotic CYP51 structures (both proto-
zoan, Hargrove et al. 2018 and human, Hargrove et al. 2020)
alters the topology of the P450 proximal surface that is known
to be involved in the interaction with the electron donor
protein partners. We conclude that the presence of substrate
in the M. capsulatus CYP51fx active site must be required for
the formation of a “productive” P450/ferredoxin complex,
one which might be tight enough to be detected crystallo-
graphically. Indeed, the P450 domain in the 6MI0 structure
(fig. 5) has a typical substrate-free (i.e., water-/inhibitor-bound
like) CYP51 conformation (Hargrove et al. 2018): the sub-
strate channel is open, the proton delivery route is closed,
and helix C is not crossing the heme plane.
When overlaid with the other substrate-free CYP51 struc-
tures, the P450 domain of M. capsulatus CYP51fx revealed the
highest similarity with protozoan T. brucei CYP51, Ca root-
mean-square deviation (Ca RMSD) of 1.6 Å. The Ca RMSDs
with human and fungal (Candida albicans) CYP51s are only
slightly larger, 1.7 and 1.9 Å, respectively (fig. 5C). The greatest
differences were observed with CYP51 from the nonsterol-
producing bacterium My. tuberculosis (Ca RMSD of 5.4 Å),
both in the conformation of the secondary structural ele-
ments that define the active site topology (fig. 5D), and in
the “eukaryotic” location of the substrate channel entrance,
on the distal P450 face, bordered by the A0 and F00 helices and
the tip of the b4 hairpin, the same as in eukaryotic CYP51
(Lepesheva et al. 2010) and unlike My. tuberculosis CYP51,
which has the channel entrance on the upper P450 face,
bordered by helix B0, B0C loop, and helix C (Podust et al. 2001).
The protein support for the heme propionates, however,
in both bacterial CYP51 structures is the same and includes
the H-bonds from only three residues: Tyr (Y79 and Y76
[M. capsulatus and My. tuberculosis, respectively], B0 helix)
and Arg (R327 and R326, b strand 1–4) to the ring A propi-
onate and His (H392, the heme bulge) to the ring D propio-
nate (fig. 5E). These three residues are invariant in all CYP51
sequences, whereas in protozoan, fungal, and animal CYP51s,
two more amino acid side chains are involved in the interac-
tion with the ring D propionate (Lepesheva et al. 2010;
Hargrove et al. 2017). One of them is a Tyr on the B00 turn
(Y116 in fig. 5E), the residue conserved across all these three
kingdoms, but always represented by Phe in plants and in
most bacteria (F92 in M. capsulatus and F89 in
My. tuberculosis CYP51, fig. 5E), although some bacterial
CYP51s, carry a Tyr in this position (table 1 and fig. 8B), like
fungal, animal, and protozoan orthologs. The other residue is
an Arg/Lys in helix C (R124 in fig. 5E). There is no conservation
of the corresponding amino acid among plant and bacterial
CYP51 sequences (N100 in M. capsulatus and K97 in
My. tuberculosis; fig. 5E, see also supplementary fig. S3A,
Supplementary Material online).
Crystal Structure of CYP51fx with the Bound Detergent
Anapoe-X-114
The crystal structure was solved to 2.4 Å resolution and also
contained one P450 molecule per asymmetric unit with no
electron density for the observed ferredoxin domain.
Although addition of substrate (either lanosterol or eburicol)
produced >95% high-spin P450 (fig. 3), and the sample
remained in the high-spin state at least until the crystal plates
were set, upon crystallization the substrate was expelled from
the CYP51 active site by the detergent: the spectra of the
dissolved crystals revealed low-spin P450, with the Soret band
maximum returned to 417 nm. In the detergent-bound struc-
ture (fig. 6A and B), the heme iron is indeed hexa-
coordinated: the detergent (23-(4-(2,4,4-trimethylpentan-2-
yl)phenoxy)-3,6,9,12,15,18,21-heptaoxatricosan-1-ol) lies
above the water molecule, which serves as the sixth (distal)
ligand, like it does in structure 6MI0, though here it is shifted
0.7 Å toward the I-helix, and its distance to the iron is 2.4 Å
(vs. 2.6 Å in 6mi0). The proximal methyl group of the deter-
gent 2,4,4-trimethylpentan moiety is hanging 4.2 Å above the
iron, the phenoxy ring plane is perpendicular to the heme
plane, with the oxygen atom directed toward the I helix. The
largest portion of the 3,6,9,12,15,18,21-heptaoxatricosan-1-ol
arm is exposed to the bulk solvent, protruding above the
protein surface. This explains its higher B-factor (supplemen-
tary table S2, Supplementary Material online), though it
anchors to the outer wall of the F00 helix through a weak
(3.7 Å) H-bond, linking oxygen atom 9 to the nitrogen of
the Gln182 side chain. Thus, contrary to all other known
CYP51-bound small molecules, the detergent must have en-
tered the active site not through the substrate access channel,
between helices A0, F00, and the tip of the b4 hairpin (although
it probably expelled the substrate via this channel), but
through the “water channel” that is sometimes seen between
helices I, F, and the tip of the b4 hairpin in the CYP51 struc-
tures (Lepesheva et al. 2010; Lepesheva and Waterman 2011)
(fig. 6A and C). It appears that the detergent reorients the
imidazole ring of His260 (the CYP51 family signature histi-
dine) involved in the proton delivery network (Hargrove et al.
2018; Hargrove et al. 2020), and its oxygen 18 forms a 3.0-Å H-
bond with the imidazole N1 atom (fig. 6A), thus interfering
with the “proper” closing of the conserved His260/Glu178 salt
bridge (3.4 Å bond length), the event expected in substrate-
free/inhibitor-bound CYP51 molecules (fig. 6D). Overall, ex-
cept for the 2 Å rearrangements in helix F00, the ligand-free
and detergent-bound structures are very similar (Ca RMSD of
0.37 Å), indicating that the closed (active) CYP51 conforma-
tion that is observed while the substrate is productively
bound in the active site does not last when it is replaced
by the detergent.
Structural Insights into the Broad Substrate Tolerance of
M. capsulatus CYP51fx
A structural explanation for the lack of obvious M. capsulatus
CYP51fx substrate preferences toward eburicol over lano-
sterol or obtusifoliol (supplementary table S1,
Supplementary Material online) could be that Ile81 in
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M. capsulatus CYP51, probably due to some structural disor-
der observed in this region, is positioned more like L134 in
human CYP51 (fig. 7), which also has similar preference for
lanosterol, eburicol, or obtusifoliol (Hargrove et al. 2016). This
is unlike the I105 in T. cruzi CYP51, which prefers eburicol over
lanosterol and even more over obtusifoliol (Lepesheva et al.
2006), or the F105 in T. brucei CYP51, which has a strict
requirement for obtusifoliol (Lepesheva et al. 2004). To fur-
ther test M. capsulatus CYP51fx substrate tolerance, we spec-
trally titrated the enzyme with three naturally occurring
lanosterol isomers, cycloartenol (the initial sterol in plants
and some bacteria), parkeol (one of the sterol end-products
in an abbreviated pathway in bacterium G. obscuriglobus
[Planctomyces]; Pearson et al. 2003), and cucurbitadienol (a
phytosterol precursor found in some plant families; Shibuya
et al. 2004). The classical type I spectral response was observed
for cycloartenol and parkeol, showing 88% and 73% low- to
high-spin transition of the heme iron with the calculated Kds
of 0.46 and 0.26mM, respectively (supplementary fig. S2A and
B, Supplementary Material online). Additionally, a modified
type I response to cucurbitadienol was seen. Based on the
Soret band maximum at 417 nm, this was probably the result
of an unproductive binding mode via a water molecule;
Kd¼ 0.67mM (supplementary fig. S2C, Supplementary
Material online). As no spectral response to these sterols is
produced by eukaryotic orthologs (human and T. cruzi
CYP51; data not shown), these results support our structural
findings. Consequently, we propose that ancestral bacterial
CYP51 may have had broad substrate specificity, and this may
be a reflection of various substrates made available to the
enzyme from preceding steps. Bacteria encode for oxidosqua-
lene cyclases (OSC) that act either as a lanosterol synthase or
a cycloartenol synthase whereas in eukaryotes generally only a
single class of OSC is found in any specific phylum (cyclo-
artenol synthase in plants and algae vs. lanosterol synthase in
animals, fungi, and protozoa). This may be of importance
because the final products of many eukaryotic sterol biosyn-
thetic pathways are utilized by other biochemical pathways
to produce other important molecules, for example, hor-
mones, brassinosteroids, signaling molecules, etc. Bacteria,
FIG. 6. Crystal structure of the detergent-bound P450 domain of Methylococcus capsulatus CYP51fx (PDB ID 6mcw). (A) Interaction of Anapoe X
114 (cyan) with surrounding residues (within 4.5 Å, shown in plum sticks and labeled). Red dotted lines are H-bonds. Selected red sphere is a water
molecule. (B) The 2F0–Fc electron density map (1.2 r) for the detergent area. Orientation is similar to that in (A). (C) Surface representation. Heme
ring A propionate (magenta) is seen through the substrate access channel. (D) Overlaid detergent-bound and ligand-free (blue, PDB ID 6mi0)
structures, Ca RMSD of 0.37 Å. Distal P450 face in both cases.
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on the other hand, may have relaxed CYP51 substrate spe-
cificity because the pathways are abbreviated and the sterol
end-product(s) is not part of downstream enzymatic
modifications.
Unfortunately, determining the complete structure of
M. capsulatus CYP51fx (which would be P450–ferredoxin
complex) by X-ray crystallography remains problematic due
to the lack of electron density for tracing the ferredoxin do-
main. The complex, at least in the absence of the substrate in
the P450 active site, is either not strong enough or (more
likely, in our opinion) the density for the small (8.4 kDa) fer-
redoxin is not seen because it can form multiple intermediate
(transient) interactions (Schilder and Ubbink 2013) with the
P450 molecule (52 kDa), reaching the/a productive binding
mode only when the substrate is bound, and the electron
transfer is expected. Indeed, to date only the X-ray structures
of two artificial (genetically engineered) P450–ferredoxin
complexes have been resolved: the cross-linked
CYP101(P450cam)-putidoredoxin (Tripathi et al. 2013) and
the partial structure of CYP11A1(P450scc)-adrenodoxin, a syn-
thetic fusion (Strushkevich et al. 2011). In both of these cases,
the P450 domain was substrate-bound. The most recently
reported structure of a self-sufficient P450 monooxygenase
CYP116B46 (a P450-reductase-ferredoxin in one polypeptide
chain), although outlining the interaction between the FMN
of the reductase domain and the Fe-S cluster of the ferredoxin
domain, does not clearly reveal the productive interaction
between the ferredoxin and the P450 domains (Zhang et al.
2020). Most likely this is because imidazole and not the sub-
strate is bound in the P450 active site. The continued work on
cocrystallization of M. capsulatus CYP51fx with bound lano-
sterol/eburicol is currently in progress, the spin state of the
P450 heme iron in the crystals being monitored prior to data
collection, as described in Materials and Methods.
Phylogenetic Analysis, Sequence Conservation, and
the Evolutionary Origins of CYP51
Strikingly, bioinformatic analysis of >247,000 bacterial
genomes (https://www.ncbi.nlm.nih.gov/genome/browse#!/
prokaryotes/) reveals that >1,000 bacteria possess a CYP51
gene even though the vast majority of them do not biosyn-
thesize sterols. Specifically, these CYP51 genes are found both
in Gram-positive and in Gram-negative bacteria that include
the Terrabacteria group [phyla Actinobacteria, Firmicutes,
Chloroflexi, and Cyanobacteria], the PVC group [phylum
Planctomycetes], the FCB group [phyla
Gemmatimonadetes, Fibrobacteres, Chlorobi, and
Bacteroidetes], and ungrouped phyla Nitrospirae,
Spirochetes, and Proteobacteria (classes Gamma, Alpha,
and Delta) (table 1 and fig. 8A). Alignment of 150 CYP51
representatives from nine bacterial phyla (including
CYP51fx fusion proteins) and their phylogenetic tree can be
seen as supplementary figure S3A and B, Supplementary
Material online, respectively. These organisms are evolution-
arily very distant, and, accordingly, their CYP51 sequence
identities across bacterial phyla are low (30–45%). Even
among order Methylococcales (where M. capsulatus belongs)
the identity varies from 98% to 52%, the mean being 70%.
The average CYP51 sequence identity in order Myxococcales
is 45% (between 32% and 79%). Nevertheless, all these
sequences possess the unique CYP51 signature motifs
(fig. 8B). The B0 helix/B0C loop conservation is essential for
the interaction with the sterol substrates, and the I-helical –
HTt(s)– triad is required for the CYP51-specific proton deliv-
ery network (Lepesheva and Waterman 2011; Hargrove et al.
2020). Our finding of CYP51 sequences in four alpha-
proteobacteria, Zavarzinia sp. HR-AS (NCBI protein accession
number WP_109905014.1), Zavarzinia compransoris
(WP_109920848.1), Oleomonas sp. K1W22B-
8 (WP_119777160.1), Novosphingobium tardaugens
(WP_021691104.1) (table 1), may indicate an alpha proteo-
bacterial ancestor of mitochondria as a source of the first
eukaryotic P450 given that Lokiarcheaum, the closest known
living archaeon relative of eukaryotes, encodes no P450 genes
(Spang et al. 2015).
Furthermore, >50 bacterial CYP51s (mostly
Proteobacteria [including three alpha-proteobacteria, family
Acetobacteraceae] but also Actinobacteria and Spirochaeta)
(noted in table 1), like M. capsulatus CYP51, are native fusion
proteins, where the P450 domain (N-terminus) is connected,
via a 20–30 residues linker, to a ferredoxin domain (C-termi-
nus). Methylococcus capsulatus-based alignment of ferredoxin
domains from bacterial CYP51fx proteins is shown as supple-
mentary figure S4, Supplementary Material online. These fer-
redoxins are 64–82 amino acid residues long, possessing three
invariant cysteines that form the sulfur–iron cluster. The FeS
cluster is responsible for the functioning of ferredoxins as
electron transfer protein partners of most bacterial and all
eukaryotic mitochondrial P450s (accepting electrons from
NADPH/NADH and transferring to the P450 heme iron).
The average sequence identity of the ferredoxin domains is
45%, ranging between 22% and 98%. Existence of such a large
FIG. 7. Ile81 in Methylococcus capsulatus CYP51 (blue, PDB ID 6mi0). A
flexible loop-like turn can be seen in the middle of the B0 helix.
Overlaid with Trypanosoma brucei (plum, PDB ID 3g1q), human
(tan, PDB ID 4uhi), and T. cruzi (green, PDB ID 4ck8) CYP51 structures.
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number of CYP51fx fusion proteins in different bacterial spe-
cies is unprecedented to date, suggesting that it is unlikely to
be a coincidence but rather provided an evolutionary advan-
tage, for example, guaranteed electron transfer in conditions
when molecular oxygen (dioxygen) was scarce in the bur-
geoning Earth atmosphere, the event preceding the forma-
tion of sterol-enforced membranes and leading to the
appearance of eukaryotic forms of life (Nes and McKean
1977).
A separate root for bacterial sequences seen in the phylo-
genetic tree that includes CYP51 representatives from each
biological kingdom (supplementary fig. S5, Supplementary
Material online) is also consistent with common ancestry
for eukaryotic CYP51s and CYP51s in modern bacteria.
Different and variable gene synteny around CYP51fx and
CYP51 genes present in the genomes of sequenced and an-
notated sterol and nonsterol-producing bacteria (fig. 9 and
supplementary fig. S6, Supplementary Material online) pro-
vides additional evidence that bacterial CYP51s are not a
result of horizontal gene transfer. On the contrary, bioinfor-
matics analysis suggests a divergence hypothesis, that is, mod-
ern bacteria that do not make sterols but whose genomes still
possess a CYP51 gene (or rather did not lose the CYP51 gene)
are derived from ancestors that used to make sterols but
evolved to stop producing them for some reasons, for exam-
ple, as symbionts, parasites, etc.
It is possible that within some species the resulting gene
product evolved to new biological function(s). Such P450s
could be recruited to other lipid (nonsterol) biochemical
pathways involved in membrane biogenesis given that
FIG. 8. CYP51 sequences from bacterial genomes. For simplicity, only one species per genus is shown. Trypanosoma brucei, T. cruzi, and human
orthologs are used as references. (A) Phylogenetic tree (rendered in TreeDyn 198.3). Colored branches represent different bacterial phyla:
Actinobacteria (blue), Cyanobacteria (cyan), Firmicutes (sky-blue), Chloroflexi (navy), Proteobacteria, a- (saddle brown), c- (dark red), d- (coral),
Planctomycetes (seagreen), Gemmatomonadales (limegreen), Nitrospirae (spring green), and Spirochetes (olive). Species that make sterols are
highlighted in bold. (B) Two CYP51 signature motives in the aligned bacterial sequences. Trypanosoma brucei numbering is presented on the top.
Residues crucial for the CYP51 function and absolutely conserved in all biological domains are in yellow. Alignment and phylogenetic tree of 150
bacterial CYP51 proteins are available as supplementary figure S3A and B, Supplementary Material online, respectively.
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many of the nonsterol-producing bacteria synthesize com-
plex lipids, for example, Mycobacteria sp. CYP51 is the third
postsqualene step of sterol biosynthesis, preceded by squa-
lene monooxygenase (SQM) and OSC reactions. In a similar
fashion, an analogous scenario seems likely for the gene
encoding SQM in bacteria. In sterol-producing bacteria, the
SQM, which utilizes atmospheric oxygen, is fixed in sterol
biosynthesis. However, it is observed that SQM genes are
also distributed and retained in nonsterol-producing bacteria,
also suggesting that these enzymes have evolved to new
function(s) as sterol biosynthesis was lost over time. In con-
trast, the OSC enzyme is seemingly only found in sterol-
producing organisms (supplementary fig. S6B and C,
Supplementary Material online). This is probably due to the
highly selective nature of the OSC catalytic reaction, being
one of the most complex biochemical reactions known (the
formation of four rings along the long chain of the substrate
[oxidosqualene], producing lanosterol). It is likely that genes
encoding OSC were not retained following loss of sterol bio-
synthesis because the complexity of its chemistry and lack of
ease of application to new substrates and functions.
Conversely, SQM and CYP51, which fix atmospheric oxygen,
could use their chemistry efficiently with other molecules in
evolving to new function(s), an example being reported for a
CYP51 evolved to new function in the biosynthesis of avena-
cin in the roots of oat plants (Qi et al. 2006). We await crystal
FIG. 9. Examples of bacterial CYP51 gene synteny. (A) CYP51fx and CYP51 genes found in sequenced and annotated genomes of sterol-producing
bacteria (M. capsulatus Bath, Methylococcus capsulatus Bath; P. pacifica, Plesiocystis pacifica; S. amylolyticus, Sandaracinus amylolyticus; E. salina,
Enhygromyxa salina; S. aurantica, Stigmatella aurantica; M. luteus, Methylobacter luteus; M. alcaliphilum, Methylomicrobium alcaliphilum; C. fuscus,
Cystobacter fuscus; C. coralloides, Corallococcus coralloides; N. excedens, Nannocystis excedens) and (B) synteny of CYP51 in Mycobacterium
tuberculosis, a representative bacterium that possess a CYP51 gene but does not make sterol. As predicted at the BioCyS Database (https://
biocyc.org/gene? orgid¼MTBH37RV&id¼G185E-4912#tab¼TU), genes RV0767c–RV0763c form a putative 6-gene operon and may act in a
pathway with CYP123.
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structural analysis of bacterial SQMs (from sterol and
nonsterol-producing species) and subsequent comparison
to the recent eukaryotic SQM structures (Padyana et al.
2019). Such comparisons may also reveal alterations in the
enzyme SQM structural architecture through evolving to new
functionality, as we have described herein for CYP51.
Conclusions
Our crystallographic data showed that the P450 domain of
the sterol-producing M. capsulatus CYP51fx enzyme displays
a greater overall structural similarity to eukaryotic CYP51s
(20–26% amino acid sequence identity) than to nonsterol-
producing My. tuberculosis CYP51, even though they share
47% amino acid sequence identity, and yet the H-bond net-
work between the apoprotein and the heme propionates in
M. capsulatus CYP51fx is the same as in My. tuberculosis
CYP51 (and presumably in plant CYP51 orthologs [no struc-
ture available yet]). This finding strongly reinforces the notion
that sterol 14a-demethylases, an essential enzyme of sterol
biosynthesis, most probably derived from a bacterial origin
and may indeed have been the ancestral progenitor for the
whole P450 superfamily (Yoshida et al. 2000). The
M. capsulatus CYP51fx enzyme may be evolutionarily closer
to a predecessor from some ancient sterol-making bacteria
that was cenancestor for: 1) all eukaryotic CYP51s (which
further diverged to enable faster sterol flow), 2) modern bac-
terial CYP51s, and 3) possibly for other bacterial P450s (which
evolved to acquire new, mostly simplified functions, such as
one-step vs. three-step monooxygenation reactions, abilities
to accommodate and metabolize compounds of various che-
motypes or to accept electrons from different protein
donors).
Finally, a wide distribution of CYP51 genes across bacterial
phyla, a broad variability of bacterial CYP51 sequences, a sep-
arate cluster in the phylogenetic tree, and particularly the fact
that bacterial CYP51 carry all of the amino acid residues that
serve as phyla-specific markers for eukaryotic CYP51 ((table 1
and fig. 8), for example, in bacterial sequences there can be I
(T. cruzi only), Y (plants/other protozoa), or L(animals/fungi)
and more rarely, M, V, or A at the position that aligns with I81
in M. capsulatus CYP51, also, there can be either F or Y (in-
variant F in plants but always Y in animals/fungi/protozoa)
that aligns with F92 (see also fig. 5E)), implies that both plant
and animal/fungi sterol biosynthesis pathways could be de-




The search for bacterial CYP51 sequences in the National
Center for Biotechnology Information sequence databases
was performed using NCBI protein–protein BLAST (TBlast
suite) (Altschul et al. 1997) and M. capsulatus CYP51 as a
protein query. Multiple sequence alignment was carried out
in Clustal Omega and analyzed in GeneDoc. The phylogenetic
tree was rendered in TreeDyn; branch support values (%)
were generated in phylogeny analysis (one-click mode:
MUSCLE-Gblocks-PyML) (http://www.phylogeny.fr/index.
cgi) (Dereeper et al. 2010).
Protein Expression and Purification
Methylococcus capsulatus CYP51fx (P450Fx native fusion) in
the pET17-b plasmid (Novagen) (Jackson et al. 2002) was
expressed in E. coli. HMS-174 (DE3) (Novagen). The expres-
sion level was 300–400 nmol l1. A single colony of bacteria
was used to inoculate 5 ml of LB media containing
0.1 mg ml1 ampicillin. An overnight culture was incubated
at 37 C and 250 rpm for 16 h and then diluted into 500 ml of
TB media supplemented with 100 mM potassium phosphate
buffer (pH 7.4) containing 0.1 mg ml1 ampicillin and 125ml
of trace elements salt solution. After incubation at 37 C and
250 rpm for 5 h, the flasks were cooled to 22 C, the cultures
were supplemented with 1 mM d-aminolevulinic acid, 1 mM
IPTG, and 1 mM FeCl3 (to ensure proper FeS cluster forma-
tion) and incubated for 20 h at 22 C and 180 rpm. The cells
were harvested by centrifugation at 1,850 g for 15 min, the
pellet was resuspended in 50 mM potassium phosphate
buffer (pH 7.4) containing 0.1 mM EDTA, 100 mM NaCl,
10% glycerol (v/v), and 0.1% Triton X-100 (v/v) (buffer A).
Lysozyme (25 mg ml1) was added, and the suspension was
placed on ice for 15 min and then, after addition of 0.5 mM
PMSF, frozen at 80 C. All purification steps were done at
4 C, and all buffers contained 0.1 mM PMSF and 0.1 mM
dithiothreitol, which were added fresh daily. The pellet was
homogenized in buffer A, the suspension was sonicated on ice
(Sonic Dismembrator model 500, Fisher Scientific), and stirred
with 0.2% Triton X-100 (v/v) at 4 C for 1 h. The solubilized
protein was separated from the insoluble material by centri-
fugation at 82,000 g for 30 min. The supernatant was frozen
in liquid nitrogen and stored at 80 C. Methylococcus cap-
sulatus CYP51fx fusion was purified in two steps, including
affinity chromatography on Ni2þ-NTA agarose, and anion
exchange chromatography on Q-Sepharose. The thawed su-
pernatant was diluted 2-fold with buffer A and applied to
Ni2þ-NTA agarose equilibrated with the same buffer and the
(NTA-) bound protein was washed with equilibration buffer
and then with 50 mM potassium phosphate buffer (pH 7.4)
containing 500 mM NaCl, 10% glycerol (v/v), and 1 mM im-
idazole until the Triton X-100 was eliminated (as judged by
A280 measurements).Then the protein was washed with
20 mM potassium phosphate buffer (pH 7.4) containing
200 mM NaCl, 10% glycerol (v/v), 5, 10, and then 15 mM
imidazole, and eluted with a linear gradient of imidazole
(20–200 mM) in 20 mM potassium phosphate buffer (pH
7.4) containing 500 mM NaCl, 10% glycerol (v/v). The frac-
tions with a spectrophotometric index (A425/A280) 1 were
pooled and concentrated using an Amicon Ultra 50K
(Millipore) to a volume of 2–4 ml. The protein was then di-
luted 25-fold with 20 mM potassium phosphate buffer (pH
8.0) containing 10% glycerol (v/v), 0.1 mM EDTA (Q buffer),
and applied to a Q-Sepharose column equilibrated with Q
buffer containing 20 mM NaCl. The column was washed with
the equilibration buffer, and the protein was eluted with
20 mM potassium phosphate buffer (pH 7.6) containing
180 mM NaCl, 10% glycerol (v/v), and 0.1 mM EDTA, pooled
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and concentrated to 500 lM. The purity and molecular
weight of the protein (63 kDa, 561 amino acid residues in
length, including 451 residues of the P450 domain, 22 residues
of the linker, 78 residues of the ferredoxin domain, and a 10
His tag at the C-terminus; Jackson et al. 2002) was confirmed
by SDS–PAGE. The correctness of the genes was confirmed by
DNA sequencing. Escherichia coli flavodoxin and flavodoxin
reductase were expressed and purified as described (Jenkins
and Waterman 1998). Spinach ferredoxin reductase was pur-
chased from Sigma.
Spectroscopic Characterization
UV-visible spectra were recorded at ambient temperature in a
dual-beam Shimadzu UV-240IPC spectrophotometer. P450
concentrations were determined from the Soret band absor-
bance in the absolute spectrum, using an absolute molar
extinction coefficient (e417) of 117 mM
1 cm1 for the low-
spin oxidized form of the protein or a difference molar ex-
tinction coefficient (De446–490) of 91 mM
1 cm1 for the
reduced carbon monoxide complex in the difference spectra.
The spin states of P450 samples were estimated from the
absolute spectra as the ratio DA393–470/DA418–470
(Lepesheva et al. 1999).
Substrate Binding Assay
Binding of lanosterol, eburicol, cycloartenol, parkeol, and
cucurbitadienol to 2 lM M. capsulatus CYP51fx was moni-
tored in a 50-mM phosphate buffer, pH 7.4, containing
100 mM NaCl and 0.1 mM EDTA. The sterols were dissolved
in 45% (w/v) 2-hydroxypropyl-b-cyclodextrin (HPCD) to
0.5 mM concentration and added in 1ml aliquots to 2 ml
protein samples (concentration range 0.25–3mM). Equal
amounts of 45% HPCD solution were added to the reference
cuvette to correct for the solvent-induced spectral perturba-
tions. The Kd values were calculated by fitting the data for the
substrate-induced absorbance changes in the difference
spectra D(AmaxAmin) versus substrate concentration to
the quadratic Morrison equation (DA=(DAmax/
2E)((Lþ EþKd)((Lþ EþKd)24LE)0.5)) using GraphPad
Prism 6 (GraphPad, La Jolla, CA).
Reconstitution of Enzymatic Activity
The sterol 14a-demethylase activity of M. capsulatus CYP51fx
was reconstituted with radiolabeled (3-3H) lanosterol, ebur-
icol, and obtusifoliol, specific activity4,000 dpm nmol1, as
described previously for CYP51 from My. tuberculosis
(Lepesheva et al. 2001), except that the sterols were added
from a 0.5-mM solution in 45% (w/v) HPCD. Escherichia coli
flavodoxin and flavodoxin reductase (molar excess over P450
18 and 2, respectively), served as electron donor partners. The
enzyme/substrate molar ratio was 1/25 (2/50mM). The final
reaction volume was 500ml and contained 20 mM MOPS (pH
7.4), 50 mM KCl, 5 mM MgCl2, 10% (v/v) glycerol,
0.4 mg ml1 isocitrate dehydrogenase, and 25 mM sodium
isocitrate. The reaction was initiated by addition of 5 mM
NADPH and stopped by extraction of the sterols with ethyl
acetate. The extracted sterols were analyzed by a reversed-
phase HPLC system (Waters) equipped with a b-RAM
detector (INUS Systems). In order to verify the ability of the
fusion M. capsulatus ferredoxin domain to transfer electrons
to the P450 domain, we used spinach ferredoxin reductase
(Jackson et al. 2002). In this case, the CYP51fx concentration
was increased to 10mM, the concentration of ferredoxin re-
ductase was 25mM. At these conditions, 25% of lanosterol
conversion was observed in a 1-h reaction.
Crystallization and Determination of the X-ray
Structures
Crystals were obtained at 24 C by vapor diffusion in hanging
drops containing equal volumes of the protein and well so-
lution. The crystals of ligand-free M. capsulatus CYP51fx were
grown from a 250-mM protein sample in 10 mM potassium
phosphate buffer (pH 7.4) containing 100 mM NaCl, 5.6 mM
tris(2-carboxyethyl)phosphine (TCEP), 5% glycerol (v/v) and
2% ANAPOE X-114 (a-[(1,1,3,3-tetramethylbutyl)phenyl]-w-
hydroxy-poly(oxy-1,2-ethanediyl)) (Anatrace) mixed with
0.2 M lithium acetate (pH 7.5) and 18% PEG 3,350 (w/v).
Methylococcus capsulatus CYP51fx was crystallized in the
presence of the detergent since it could not be crystallized
in its absence. The crystals of M. capsulatus CYP51fx in com-
plex with the detergent were obtained in an attempt to
cocrystallize substrate-bound protein, because we expected
that binding of the substrate should induce the large-scale
conformational rearrangement in the CYP51 molecule, which
should strengthen P450–ferredoxin interaction (Hargrove
et al. 2018; Hargrove et al. 2020). The M. capsulatus
CYP51fx sample (5 lM in 20 mM potassium phosphate
buffer [pH 7.4] containing 200 mM NaCl, 5.6 mM TCEP,
and 10% glycerol [v/v]) was gradually saturated with eburicol
(using a 0.5-mM stock solution in 45% [w/v] HPCD, because
of the limited solubility of this highly hydrophobic sterol, Log
P 8.6; Hargrove et al. 2018), incubated for 20 min at room
temperature, concentrated using an Amicon Ultra 50K
(Millipore) to 500mM, diluted 2-fold with 5 mM phosphate
buffer (pH 7.4), and mixed with ANAPOE X-114 (final con-
centration 2%). The high-spin (substrate-bound) state of the
P450 heme in the mixture was spectrally confirmed. The well
solution consisted of 0.2 M lithium acetate (pH 7.5) and 15%
PEG 6,000 (w/v). After harvesting, crystals were cryoprotected
with 25% (v/v) glycerol and frozen in liquid nitrogen. The X-
ray diffraction data were collected at the Advanced Photon
Source, Argonne National Laboratory, 21-ID-F (0.97872 nm),
and 21-ID-D (1.07807 nm) beamlines, respectively. The dif-
fraction images were processed with HKL-2000, and crystal
structures solved by molecular replacement with Phaser MR
(CCP4 Program Suite; Potterton et al. 2003) using T. brucei
CYP51 (PDB ID 3g1q) as a search model. The structure was
built with Coot (Emsley et al. 2010) and refined with Refmac5
(CCP4 Suite). Details of the data collection and refinement
statistics are listed in supplementary table S2, Supplementary
Material online. After determining the structure and observ-
ing ANAPOE X-114 instead of the substrate in the P450 active
site, the crystals were reproduced at the same conditions,
harvested, dissolved in 10 mM potassium phosphate buffer
(pH 7.4) containing 100 mM NaCl, 5.6 mM TCEP, and 5%
glycerol (v/v), and the absorbance spectra (2ml samples)
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were taken using a Nanovue 4282 V1.7.3 spectrophotometer
as described previously (Hargrove et al. 2018). The Soret max-
imum of the enzyme was 417 nm, exactly corresponding to
the low-spin water coordinated P450 (see fig. 6A) and indi-
cating that the detergent replaced the substrate upon crys-
tallization. Structure superimposition and RMSD calculation
was performed in lsqcab (CCP4 Suite). Molecular graphics
were rendered using Chimera. The model of M. capsulatus
ferredoxin was built in Modeler (CCP4 Suite) based on the
structure of adrenodoxin (PDB ID 1AYF) with 32 truncated
amino acid residues at the N-terminus.
Supplementary Material
Supplementary data are available at Molecular Biology and
Evolution online.
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